Answers are grounded in this paper and cite their sources.
Bone and bone-deficiency diseases represent a significant clinical challenge, particularly in maxillofacial and orthopedic surgery. Although bone possesses considerable healing capacity, this is insufficient in cases of substantial defects. Various approaches have been proposed, including autograft, allograft, and alloplastic bioactive bone substitutes. This study compares MPGA-based 3D-printable hydrogel (HG), β-tricalcium phosphate-filled hydrogel composite (BTCP-HG), and aerogel/BTCP-filled hydrogel (AE/BTCP-HG) scaffolds for in vitro and in vivo investigations. The 3D-printed composite hydrogels exhibited Young's modulus values of 0.1028 ± 0.041 MPa for BTCP-HG and 0.3350 ± 0.138 MPa for AE/BTCP-HG, corresponding to an approximately 3.3-fold increase in stiffness for the aerogel-containing composite. Reossification and biodegradibilty appeared strongest with BTCP-HG scaffold with histological, imaging, biochemical and semiquantitative assessments, allowing anti-inflammatory microenvironment by early significant drop of CD68 + macrophages (1st month: 76.5 ± 7.2 vs. 3rd month: 3.25 ± 1.18 cells/section); confirmed also by high alkaline phosphatase activity. AE/BTCP-HG also displayed strong regenerative potential due to Si content, the consequent type I collagen build-up however, remained unmineralized until the 6th month, though subsequently, collagen is critical for hydroxyapatite deposition. Doubled pro-inflammatory CD68 + macrophages (1st month: 12.12 ± 1.2 vs. 6th month: 27.87 ± 1.87 cells/section) proximal to AE/BTCP-HG also tempts to confirm the promising regenerative potential. Our newly developed light-curing, degradable PGA-based hydrogel composite shows promising potential for maxillofacial applications. A key advantage is its rapid digital design capability and compatibility with vat-photopolymerization. Our in vitro and in vivo experiments indicate that BTCP and AE/BTCP bioceramics embedded in hydrogels can facilitate prolonged bone formation through a sustained slow-release mechanism.
No takes yet. Share an insight, caveat, or question.
Hegedűs et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: